ATE260896T1 - Donepezil polykristalle und verfharen zu ihrer herstellung - Google Patents
Donepezil polykristalle und verfharen zu ihrer herstellungInfo
- Publication number
- ATE260896T1 ATE260896T1 AT98956013T AT98956013T ATE260896T1 AT E260896 T1 ATE260896 T1 AT E260896T1 AT 98956013 T AT98956013 T AT 98956013T AT 98956013 T AT98956013 T AT 98956013T AT E260896 T1 ATE260896 T1 AT E260896T1
- Authority
- AT
- Austria
- Prior art keywords
- donepezil
- polycrystals
- production
- producing
- handleability
- Prior art date
Links
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 title abstract 6
- 229960003530 donepezil Drugs 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 229960003135 donepezil hydrochloride Drugs 0.000 abstract 1
- XWAIAVWHZJNZQQ-UHFFFAOYSA-N donepezil hydrochloride Chemical compound [H+].[Cl-].O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 XWAIAVWHZJNZQQ-UHFFFAOYSA-N 0.000 abstract 1
- 230000004526 pharmaceutical effect Effects 0.000 abstract 1
- 238000000634 powder X-ray diffraction Methods 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 239000013557 residual solvent Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP33616597 | 1997-12-05 | ||
| PCT/JP1998/005405 WO1999029668A1 (en) | 1997-12-05 | 1998-12-01 | Donepezil polycrystals and process for producing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE260896T1 true ATE260896T1 (de) | 2004-03-15 |
Family
ID=18296352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98956013T ATE260896T1 (de) | 1997-12-05 | 1998-12-01 | Donepezil polykristalle und verfharen zu ihrer herstellung |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6245911B1 (de) |
| EP (1) | EP1048653B1 (de) |
| AT (1) | ATE260896T1 (de) |
| DE (1) | DE69822218T2 (de) |
| DK (1) | DK1048653T3 (de) |
| ES (1) | ES2218869T3 (de) |
| PT (1) | PT1048653E (de) |
| WO (1) | WO1999029668A1 (de) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2133078A1 (de) | 2000-03-03 | 2009-12-16 | Eisai R&D Management Co., Ltd. | Verwendung eines Cholinesterase-Hemmers für die Behandlung von kognitiven Beeinträchtigungen und/oder Demenz, die mit Gehirntumoren in Zusammenhang gebracht oder davon verursacht wird |
| US20060183776A9 (en) * | 2000-03-03 | 2006-08-17 | Eisai Co., Ltd. | Liquid dosage formulations of donepezil |
| JP2003530437A (ja) * | 2000-04-13 | 2003-10-14 | マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ | Ａβ４２低下物質 |
| US20060173064A1 (en) * | 2001-08-24 | 2006-08-03 | Lippa Arnold S | (-)-1-(3,4-Dichlorophenyl)-3-azabi cyclo[3.1.0]hexane, compositions thereof, and uses for treating alcohol-related disorders |
| US6569887B2 (en) * | 2001-08-24 | 2003-05-27 | Dov Pharmaceuticals Inc. | (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake |
| US20080081834A1 (en) | 2002-07-31 | 2008-04-03 | Lippa Arnold S | Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders |
| US20060014801A1 (en) * | 2002-11-22 | 2006-01-19 | The Johns Hopkins University | Prevention and treatment of cognitive impairment using (R)-(-)-5-methyl-1-nicotynoyl-2-pyrazoline (MNP) and analogs |
| WO2004071431A2 (en) * | 2003-02-05 | 2004-08-26 | Myriad Genetics, Inc. | Method and composition for treating neurodegenerative disorders |
| US7439365B2 (en) * | 2003-11-17 | 2008-10-21 | Usv, Ltd. | Pharmaceutical salt of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine (Donepezil) |
| WO2004087660A1 (en) * | 2003-04-02 | 2004-10-14 | Hetero Drugs Limited | A novel process for amorphous form of donepezil hydrochloride |
| WO2005065645A2 (en) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Donepezil formulations |
| WO2006001877A2 (en) * | 2004-04-13 | 2006-01-05 | Myriad Genetics, Inc. | Combination treatment for neurodegenerative disorders comprising r-flurbiprofen |
| AU2005241023A1 (en) * | 2004-04-29 | 2005-11-17 | Keystone Retaining Wall Systems, Inc. | Veneers for walls, retaining walls and the like |
| WO2005112946A1 (en) * | 2004-05-14 | 2005-12-01 | The Johns Hopkins University | Method for improving cognitive function by co-administration of a gabab receptor antagonist and an acetylcholinesterase inhibitor |
| EP1773339A4 (de) * | 2004-07-30 | 2009-07-29 | Reddys Lab Ltd Dr | Kristalline form von donepezil-hydrochlorid |
| WO2006020850A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
| WO2006020852A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
| BRPI0514303A (pt) * | 2004-08-11 | 2008-06-10 | Myriad Genetics Inc | composição farmacêutica e método para tratar distúrbios neurodegenerativos |
| US20070043100A1 (en) * | 2005-08-16 | 2007-02-22 | Hagen Eric J | Novel polymorphs of azabicyclohexane |
| WO2006035433A2 (en) * | 2004-09-29 | 2006-04-06 | Chemagis Ltd. | Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride |
| US20060100263A1 (en) * | 2004-11-05 | 2006-05-11 | Anthony Basile | Antipyretic compositions and methods |
| AP2007003979A0 (en) * | 2004-11-23 | 2007-06-30 | Warner Lambert Co | 7-(2h-pyrazol-3-yl)-3,5-dihyroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for thetreatment of lipidemia |
| US20060122226A1 (en) * | 2004-12-08 | 2006-06-08 | Itai Adin | Crystalline forms of Donepezil base |
| AU2006232517A1 (en) * | 2005-04-04 | 2006-10-12 | Eisai R&D Management Co., Ltd. | Dihydropyridine compounds and compositions for headaches |
| CA2615063A1 (en) * | 2005-07-22 | 2007-02-01 | Myriad Genetics, Inc. | High drug load formulations and dosage forms |
| EP1915146A4 (de) | 2005-07-27 | 2010-06-02 | Dov Pharmaceutical Inc | Neuartige 1-aryl-3-azabicyclo[3.1.0]hexane. herstellung und verwendung zur behandlung von neuropsychiatrischen erkrankungen |
| WO2007018801A1 (en) * | 2005-07-28 | 2007-02-15 | Teikoku Pharma Usa, Inc. | Gelled donepezil compositions and methods for making and using the same |
| WO2007108011A2 (en) * | 2006-03-20 | 2007-09-27 | Ind-Swift Laboratories Limited | Process for the preparation of highly pure donepezil |
| US20080045725A1 (en) | 2006-04-28 | 2008-02-21 | Murry Jerry A | Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane |
| JP5097359B2 (ja) | 2006-05-09 | 2012-12-12 | 久光製薬株式会社 | ドネペジル経皮吸収型製剤 |
| WO2008006099A2 (en) * | 2006-07-07 | 2008-01-10 | Myriad Genetics, Inc. | Treatment of psychiatric disorders |
| WO2008050351A1 (en) * | 2006-10-25 | 2008-05-02 | Jubilant Organosys Limited | NOVEL POLYMORPHIC FORMS OF l-BENZYL-4-[(5,6-DIMETHOXY-l-INDANONE)-2-YL]METHYL PIPERIDINE [DONEPEZIL] AND PROCESS FOR PREPARING THE SAME |
| WO2008051599A2 (en) | 2006-10-27 | 2008-05-02 | Medivation Neurology, Inc. | Combination therapies for treating alzheimer's disease using i. a. dimebon and dolepezil |
| US8138377B2 (en) * | 2006-11-07 | 2012-03-20 | Dov Pharmaceutical, Inc. | Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use |
| US20080269348A1 (en) * | 2006-11-07 | 2008-10-30 | Phil Skolnick | Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use |
| WO2008111590A2 (en) * | 2007-03-05 | 2008-09-18 | Eisai R & D Management Co., Ltd. | Ampa and nmda receptor antagonists for neurodegenerative diseases |
| WO2008139984A1 (en) * | 2007-04-26 | 2008-11-20 | Eisai R & D Management Co., Ltd. | Cinnamide compounds for dementia |
| EP2167083B1 (de) * | 2007-06-06 | 2015-10-28 | Euthymics Bioscience, Inc. | 1- heteroaryl-3-azabicyclo[3.1.0]hexane, verfahren zu ihrer herstellung und ihre verwendung als medikamente |
| US9133159B2 (en) | 2007-06-06 | 2015-09-15 | Neurovance, Inc. | 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments |
| WO2010071216A1 (en) | 2008-12-17 | 2010-06-24 | Eisai R&D Management Co., Ltd. | Polymorphic crystal of donepezil and process for producing the same |
| AU2011215870B2 (en) * | 2010-02-09 | 2016-01-28 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| EP2366378A1 (de) | 2010-03-01 | 2011-09-21 | Dexcel Pharma Technologies Ltd. | Donepezilformulierungen mit verzögerter Freisetzung |
| US20110251239A1 (en) | 2010-04-07 | 2011-10-13 | Eisai Inc. | Combination therapy for the treatment of dementia |
| WO2011151359A1 (en) | 2010-06-02 | 2011-12-08 | Noscira, S.A. | Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative |
| US20130267560A1 (en) | 2010-10-22 | 2013-10-10 | Cadila Healthcare Limited | Sustained release pharmaceutical compositions of donepezil |
| US20140206740A1 (en) | 2011-07-30 | 2014-07-24 | Neurovance, Inc. | Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters |
| US20140206667A1 (en) | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia |
| JP6433482B2 (ja) | 2013-03-15 | 2018-12-05 | エージンバイオ， インコーポレイテッド | 認知機能を改善するための方法および組成物 |
| WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| AU2014307803A1 (en) | 2013-08-16 | 2016-03-10 | Universiteit Maastricht | Treatment of cognitive impairment with PDE4 inhibitor |
| CN107531958B (zh) | 2015-05-08 | 2020-11-06 | 陶氏环球技术有限责任公司 | 使用偶氮二甲酰胺/柠檬酸盐混合物作为成核剂来发泡聚烯烃组合物的工艺 |
| WO2016191288A1 (en) | 2015-05-22 | 2016-12-01 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
| US10369187B2 (en) | 2017-02-09 | 2019-08-06 | Vanderbilt University | Peptide regulators of JNK family kinases |
| BR112020004144B1 (pt) | 2017-10-06 | 2023-10-10 | Lenzing Aktiengesellschaft | Dispositivo para a extrusão de filamentos, emprego de um dispositivo para a extrusão de filamentos e processo para produção de dispositivo para a extrusão de filamentos |
| EP3969643B1 (de) | 2019-05-17 | 2023-11-15 | Lenzing Aktiengesellschaft | Verfahren und vorrichtung zur düsenreinigung während der herstellung von cellulosischem spinnvlies |
| CN112939846B (zh) * | 2019-11-26 | 2023-12-26 | 中国科学院上海药物研究所 | 一种乙酰胆碱酯酶抑制剂的晶型及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI95572C (fi) | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
| SK285312B6 (sk) | 1996-06-07 | 2006-10-05 | Eisai Co., Ltd. | Polymorf (III) donepezil hydrochloridu, spôsob jeho výroby a terapeutický prostriedok s jeho obsahom |
| TW513409B (en) * | 1996-06-07 | 2002-12-11 | Eisai Co Ltd | Polymorphs of donepezil hydrochloride |
| JPH1053576A (ja) | 1996-06-07 | 1998-02-24 | Eisai Co Ltd | 塩酸ドネペジルの多形結晶およびその製造法 |
-
1998
- 1998-12-01 ES ES98956013T patent/ES2218869T3/es not_active Expired - Lifetime
- 1998-12-01 EP EP98956013A patent/EP1048653B1/de not_active Expired - Lifetime
- 1998-12-01 WO PCT/JP1998/005405 patent/WO1999029668A1/ja not_active Ceased
- 1998-12-01 AT AT98956013T patent/ATE260896T1/de active
- 1998-12-01 PT PT98956013T patent/PT1048653E/pt unknown
- 1998-12-01 DE DE69822218T patent/DE69822218T2/de not_active Expired - Lifetime
- 1998-12-01 DK DK98956013T patent/DK1048653T3/da active
- 1998-12-01 US US09/555,807 patent/US6245911B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999029668A1 (en) | 1999-06-17 |
| DE69822218T2 (de) | 2005-02-03 |
| US6245911B1 (en) | 2001-06-12 |
| PT1048653E (pt) | 2004-07-30 |
| EP1048653A4 (de) | 2001-03-07 |
| DE69822218D1 (de) | 2004-04-08 |
| EP1048653A1 (de) | 2000-11-02 |
| DK1048653T3 (da) | 2004-05-24 |
| EP1048653B1 (de) | 2004-03-03 |
| ES2218869T3 (es) | 2004-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE260896T1 (de) | Donepezil polykristalle und verfharen zu ihrer herstellung | |
| MA23257A1 (fr) | Nouvelle forme de compose demagnesium d'omeprazole etson utilisation . | |
| ATE174920T1 (de) | Pyridothiadiazine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
| NO941678D0 (no) | nor-gallesyrederivater, fremgangsmåte for fremstilling og anvendelse av dem som legemiddel | |
| NO933200D0 (no) | Substituerte cykloheksanderivater, fremgangsm}te til fremstilling derav og anvendelsen av forbindelsene til behandling av sykdommer | |
| AU656466B2 (en) | New benzimidazole compounds, a process for their preparation and pharmaceutical compositions containing them | |
| ATE118001T1 (de) | 1,3-dihydro-1-(pyridinylamino)-2h-indol-2-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| ATE111909T1 (de) | Heterocyclisch substituierte dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln. | |
| AU8777691A (en) | Novel compounds of n-benzoylproline, process for their preparation and pharmaceutical compositions containing them | |
| ATE47856T1 (de) | 11-substituierte 5h,11h-pyrrolo(2,1c>(1,4>benzoxazepine, ein verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| ZA944728B (en) | alph -amino acid compounds a process for the preparation thereof and pharmaceutical compositions containing them | |
| ATE172976T1 (de) | 3-aminochroman-spiroderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| BR9103676A (pt) | Processo para a elaboracao de residuos de reacao da producao de dioxido de titanio | |
| DK0401623T3 (da) | Fremgangsmåde til fremstilling af 7-(3-amino- og 3-aminomethyl-1-pyrrolidinyl)-3-quinoloncarboxylsyrer og -napthyridoncarbo | |
| EA199800364A1 (ru) | Новая кристаллическая форма морфин-6-глюкуронида | |
| ATE80890T1 (de) | Anthracyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| ATE170520T1 (de) | Eburnan-derivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| CA2149007A1 (en) | Cyclohexane derivatives, process for their preparation, and the use of the compounds for the treatment of diseases | |
| CS368890A3 (en) | Aminooligohydroxy derivatives inhibiting effects of renin, process for their preparation and a pharmaceutical containing them | |
| HU9800277D0 (en) | Sulfonamid-substituted compounds, process for producing them, their use as medicines and diagnostics, and pharmaceutical compositions containing said compounds | |
| HU9303505D0 (en) | Process for producing organic compound | |
| ATE173734T1 (de) | Heteroarenylpiperazine, verfahren zu ihrer herstellung und ihre anwendung als medikamente | |
| PT1462439E (pt) | Novos cristais estáveis de derivado do ácido fenilpropiónico substituído e processo para a sua produção | |
| ZA9811493B (en) | Process for producing (r)-3-hydroxy-4-butyrolactone useful for preparing (r)-carnitine | |
| HUP9603201A3 (en) | Substituted benzene dicarboxylic acid diguanidides, process for producing them, their use for preparing pharmaceutical compositions and diagnostics and pharmaceutical compositions containing the said compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1048653 Country of ref document: EP |